Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis

计划入组 120 人 · 首次发布于 2026 年 5 月 15 日

ALPPS Versus PVE/PL

计划入组 100 人 · 首次发布于 2014 年 8 月 13 日

NanoFUSE® PL Gutter PMCF

计划入组 50 人 · 首次发布于 2018 年 11 月 23 日

beta blocker (NuMedii)

Beta-blocker(Selectus)

PL-9654

Frantz Viral Therapeutics, LLC

United States

VIETNAM VIRAL HEPATITIS ALLIANCE

United States

Advanced Viral Research Corp

The Bahamas

Polyrizon Submits FDA Pre-Request for PL-16 Viral Blocker with Over 90% Efficacy Against Respiratory Viruses

Polyrizon's Intranasal Barrier Technology Shows Promise Against Respiratory Viruses and Allergens

Polyrizon Secures Manufacturing Agreement with Eurofins CDMO for PL-14 Allergy Blocker